Story perspectives

New Antibiotic Could Revolutionize MRSA and VRE Treatment

10/31/2025

33 7

Summary

Story summary

Researchers from Warwick University and Monash University identified pre-methylenomycin C lactone, a new antibiotic from Streptomyces coelicolor.
The compound is an intermediate in methylenomycin A production and is 100 times more effective against Gram-positive bacteria than its predecessor.
Lab tests suggest it could combat MRSA and VRE, with bacteria not developing resistance after extended exposure.
The findings were published in the Journal of the American Chemical Society.

1 of 1

Story summary

Researchers from Warwick University and Monash University identified pre-methylenomycin C lactone, a new antibiotic from Streptomyces coelicolor.
The compound is an intermediate in methylenomycin A production and is 100 times more effective against Gram-positive bacteria than its predecessor.
Lab tests suggest it could combat MRSA and VRE, with bacteria not developing resistance after extended exposure.
The findings were published in the Journal of the American Chemical Society.